Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease
| dc.contributor.author | Bou-Fakhredin, Rayan | |
| dc.contributor.author | Halawi, Racha | |
| dc.contributor.author | Roumi, Joseph El | |
| dc.contributor.author | Taher, Ali T. | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:49:34Z | |
| dc.date.available | 2025-01-24T11:49:34Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Introduction: Iron deficiency is a frequent comorbidity of chronic diseases such as inflammatory bowel disease that can severely impact the health and quality of life of affected individuals. It can exist as a silent condition and manifest in non-specific symptoms even in the absence of anemia. Even though iron deficiency anemia is the most common complication and extra-intestinal manifestation of inflammatory bowel disease, the majority of inflammatory bowel disease patients who are diagnosed with iron deficiency anemia are not treated. Areas covered: In this review, we discuss iron deficiency and iron deficiency anemia in patients with inflammatory bowel disease, and review diagnostic and therapeutic options. Expert commentary: We invite international gastroenterological societies and associations to refine the practice guidelines and include iron deficiency as a potential morbidity associated with IBD in analogy to arthritis, uveitis or any other extra intestinal manifestations. There should a more unanimous agreement among different societies on the specific diagnostic cutoff values for C-reactive protein levels, serum ferritin, and transferrin saturation in order to differentiate iron deficiency anemia from anemia of chronic disease. © 2017 Informa UK Limited, trading as Taylor & Francis Group. | |
| dc.identifier.doi | https://doi.org/10.1080/17474086.2017.1355233 | |
| dc.identifier.eid | 2-s2.0-85028939999 | |
| dc.identifier.pmid | 28701106 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30896 | |
| dc.language.iso | en | |
| dc.publisher | Taylor and Francis Ltd | |
| dc.relation.ispartof | Expert Review of Hematology | |
| dc.source | Scopus | |
| dc.subject | Anemia of chronic disease | |
| dc.subject | Inflammatory bowel disease | |
| dc.subject | Intravenous iron | |
| dc.subject | Iron deficiency | |
| dc.subject | Iron deficiency anemia | |
| dc.subject | Oral iron | |
| dc.subject | Algorithms | |
| dc.subject | Anemia | |
| dc.subject | Anemia, iron-deficiency | |
| dc.subject | Disease management | |
| dc.subject | Drug administration routes | |
| dc.subject | Humans | |
| dc.subject | Inflammatory bowel diseases | |
| dc.subject | Iron | |
| dc.subject | Practice guidelines as topic | |
| dc.subject | Treatment outcome | |
| dc.subject | Disease association | |
| dc.subject | Follow up | |
| dc.subject | Human | |
| dc.subject | Iron therapy | |
| dc.subject | Nonhuman | |
| dc.subject | Phase 3 clinical trial (topic) | |
| dc.subject | Priority journal | |
| dc.subject | Review | |
| dc.subject | Algorithm | |
| dc.subject | Complication | |
| dc.subject | Drug administration route | |
| dc.subject | Metabolism | |
| dc.subject | Practice guideline | |
| dc.title | Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease | |
| dc.type | Review |
Files
Original bundle
1 - 1 of 1